as 11-15-2024 4:00pm EST
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Founded: | 1976 | Country: | United States |
Employees: | N/A | City: | FARMINGDALE |
Market Cap: | 59.7M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 122.4K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | Dividend Payout Frequency: | N/A | |
EPS: | -0.51 | EPS Growth: | N/A |
52 Week Low/High: | $0.99 - $1.50 | Next Earning Date: | 12-13-2024 |
Revenue: | $31,907,000 | Revenue Growth: | 2.72% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
ENZ Breaking Stock News: Dive into ENZ Ticker-Specific Updates for Smart Investing
Simply Wall St.
17 days ago
Simply Wall St.
17 days ago
Zacks
18 days ago
GlobeNewswire
19 days ago
Verdict
3 months ago
Zacks
5 months ago
Simply Wall St.
5 months ago
Zacks
5 months ago
The information presented on this page, "ENZ Enzo Biochem Inc. ($0.01 Par Value) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.